Advertisement

Renal Replacement Therapy in the Critically Ill Surgical Patient

  • Kevin K. Chung
  • Ian J. Stewart
Chapter

Abstract

The diagnosis of clinically significant acute kidney injury (AKI) among the critically ill surgical population occurs in approximately one in four admissions [1]. About 5 % of all patients admitted to the intensive care unit (ICU), or 1 out of every 20 admissions, require some form of renal replacement therapy (RRT) [1]. Among all critically ill patients who require RRT, the mortality has consistently been around 60 % [2]. Practically speaking, RRT refers to the clearance of excessive electrolytes, toxic solutes, and volume that accumulates in the intravascular and extravascular space in the setting of AKI. Most often, this type of therapy is delivered via a venovenous extracorporeal circuit with a blood pump that drives venous blood through an artificial “kidney” membrane. Less commonly, the peritoneal cavity could be used to exchange electrolytes and solutes in the form of peritoneal dialysis. We will focus our discussion in this chapter mainly on extracorporeal RRT with only a brief section on peritoneal dialysis.

Keywords

Renal replacement therapy Hemofiltration Hemodialysis Continuous Acute kidney injury Surgical critical care 

References

  1. 1.
    Dennen P, Douglas IS, Anderson R. Acute kidney injury in the intensive care unit: an update and primer for the intensivist. Crit Care Med. 2010;38:261–75.CrossRefPubMedGoogle Scholar
  2. 2.
    Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Henrich WL, Woodard TD, Blachley JD, et al. Role of osmolality in blood pressure stability after dialysis and ultrafiltration. Kidney Int. 1980;18:480–8.CrossRefPubMedGoogle Scholar
  4. 4.
    The FHN Trial Group. In-Center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363:2287–300.CrossRefPubMedCentralGoogle Scholar
  5. 5.
    Joannidis M, Oudemans-van Straaten HM. Clinical review: patency of the circuit in continuous renal replacement therapy. Crit Care. 2007;11:218.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Kumar VA, Craig M, Depner TA, Yeun JY. Extended daily dialysis: a new approach to renal replacement for acute renal failure in the intensive care unit. Am J Kidney Dis. 2000;36:294–300.CrossRefPubMedGoogle Scholar
  7. 7.
    Salahudeen AK, Kumar V, Madan N, et al. Sustained Low Efficiency Dialysis in the continuous mod (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients. Clin J Am Soc Nephrol. 2009;4:1338–46.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Scoville BA, Mueller BA. Medication dosing in critically ill patients with acute kidney injury treated with renal replacement therapy. Am J Kidney Dis. 2013;61:490–500.CrossRefPubMedGoogle Scholar
  9. 9.
    Zhang L, Yang J, Eastwood GM, et al. Extended daily dialysis versus continuous renal replacement therapy for acute kidney injury: a meta-analysis. Am J Kidney Dis. 2015;66:322.CrossRefPubMedGoogle Scholar
  10. 10.
    Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.CrossRefGoogle Scholar
  11. 11.
    Palevsky PM, Zhang JH, O’Connor TZ, et al. for the VA/NIH Acute Renal Failure Trial Network. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359:7–20.Google Scholar
  12. 12.
    Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361:1627–38.CrossRefPubMedGoogle Scholar
  13. 13.
    Davenport A. Renal replacement therapy in the patient with acute brain injury. Am J Kidney Dis. 2001;37:457–66.CrossRefPubMedGoogle Scholar
  14. 14.
    Vinsonneau C, Camus C, Combes A, et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomized trial. Lancet. 2006;368:379–85.CrossRefPubMedGoogle Scholar
  15. 15.
    Chung KK, Juncos LA, Wolf SE, et al. Continuous renal replacement therapy improves survival in severely burned military casualties with acute kidney injury. J Trauma. 2008;64:S179–87.CrossRefPubMedGoogle Scholar
  16. 16.
    Elahi MM, Lim MY, Joseph RN, et al. Early hemofiltration improves survival in post-cardiotomy patients with acute renal failure. Eur J Cardiothorac Surg. 2004;26:1027–31.CrossRefPubMedGoogle Scholar
  17. 17.
    Vidal S, Richebe P, Barandon L, et al. Evaluation of continuous veno-venous hemofiltration for the treatment of cardiogenic shock in conjunction with acute renal failure after cardiac surgery. Eur J Cardiothorac Surg. 2009;36:572–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Wong LP, Blackley MP, Andreoni KA, et al. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int. 2005;68:362–70.CrossRefPubMedGoogle Scholar
  19. 19.
    Schneider AG, Bellomo R, Bagshaw SM, et al. Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis. Intensive Care Med. 2013;39:987–97.CrossRefPubMedGoogle Scholar
  20. 20.
    Wald R, Shariff S, Adhikari NK, et al. The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study. Crit Care Med. 2014;42:868–77.CrossRefPubMedGoogle Scholar
  21. 21.
    Palevsky PM, O’Connor TZ, Chertow GM, et al. Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study. Crit Care. 2009;13:310.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Gallegher M, Cass A, Bellomo R, et al. Long-term survival and dialysis dependency following acute kidney injury in intensive care: extended follow-up of a randomized controlled trial. PLoS Med. 2014;11:e1001601.CrossRefGoogle Scholar
  23. 23.
    Conger JD. A controlled evaluation of prophylactic dialysis in post-traumatic acute renal failure. J Trauma. 1975;15:1056–63.CrossRefPubMedGoogle Scholar
  24. 24.
    Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, et al. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med. 2002;30:2205–11.CrossRefPubMedGoogle Scholar
  25. 25.
    Karvellas CJ, Farhat MR, Sajjad I, et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care. 2011;15:R72.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Barbar SD, Binquet C, Monchi M, et al. Impact on mortality of the timing of renal replacement therapy in patients with severe acute kidney injury in septic shock: the IDEAL-ICU study (initiation of dialysis early versus delayed in the intensive care unit): study protocol for a randomized controlled trial. Trials. 2014;15:270.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Smith OM, Wald R, Adhikari NK, et al. Standard versus accelerated initiation of renal replacement therapy in acute kidney injury (STARRT-AKI): study protocol for a randomized controlled trial. Trials. 2013;14:320.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Parienti JJ, Megarbane B, Fischer MO, et al. Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study. Crit Care Med. 2010;38:1118–25.CrossRefPubMedGoogle Scholar
  29. 29.
    Parienti JJ, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA. 2008;299:2413–22.CrossRefPubMedGoogle Scholar
  30. 30.
    Gammelager H, Christiansen CF, Berg M, et al. Five-year risk of end-stage renal disease among intensive care patients surviving dialysis-requiring acute kidney injury: a nationwide cohort study. Crit Care. 2013;17:R145.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Schillinger F, Schillinger D, Montagnac R, Milcent T. Post catheterisation vein stenosis in haemodialysis: comparative angiographic study of 50 subclavian and 50 internal jugular accesses. Nephro Dial Transplant. 1991;6:722–4.CrossRefGoogle Scholar
  32. 32.
    Tolwani AJ, Wille KM. Anticoagulation for continuous renal replacement therapy. Semin Dial. 2009;22:141.CrossRefPubMedGoogle Scholar
  33. 33.
    Kutsogiannis DJ, Gibney RT, Stollery D, Gao J. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int. 2005;67:2361–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Morabito S, Pistolesi V, Tritapepe L, Fiaccadori E. Regional citrate anticoagulation for RRTs in critically ill patients with AKI. Clin J Am Soc Nephrol. 2014;9:2173–88.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Butenas S, Mann KG. Blood coagulation. Biochemistry (Mosc). 2002;67:3–12.CrossRefGoogle Scholar
  36. 36.
    Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013;61:649–72.CrossRefPubMedGoogle Scholar
  37. 37.
    Gattas DJ, Rajbhandari D, Bradford C, et al. A randomized controlled trial of regional citrate versus regional heparin anticoagulation for continuous renal replacement therapy in critically ill adults. Crit Care Med. 2015;43:1622 [Epub ahead of print].CrossRefPubMedGoogle Scholar
  38. 38.
    Schilder L, Nurmohamed SA, Bosch FH, et al. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial. Crit Care. 2014;18:472.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Stucker F, Ponte B, Tataw J, et al. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial. Crit Care. 2015;19:91.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Link A, Girndt M, Selejan S, et al. Argatroban for anticoagulation in continuous renal replacement therapy. Crit Care Med. 2009;37:105–10.CrossRefPubMedGoogle Scholar
  41. 41.
    Kiser TH, MacLaren R, Fish DN, et al. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy. Pharmacotherapy. 2010;30:1117–26.CrossRefPubMedGoogle Scholar
  42. 42.
    Heintz BH, Matzke GR, Dager WE. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis. Pharmacotherapy. 2009;29:562–77.CrossRefPubMedGoogle Scholar
  43. 43.
    Jamal JA, Mueller BA, Choi GY, et al. How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy? Diagn Microbiol Infect Dis. 2015;82:92–103.CrossRefGoogle Scholar
  44. 44.
    Hoste EA, Dhondt A. Clinical review: use of renal replacement therapies in special groups of ICU patients. Crit Care. 2012;16:201.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Mathew RO, Cerda J. Renal replacement therapy in special situations: heart failure and neurological injury. Semin Dial. 2011;24:192–6.CrossRefPubMedGoogle Scholar
  46. 46.
    Cullis B, Abdelraheem M, Abrahams G, et al. Peritoneal dialysis for acute kidney injury. Perit Dial Int. 2014;34:494–517.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    George J, Varma S, Kumar S, et al. Comparing continuous venovenous hemodiafiltration and peritoneal dialysis in critically ill patients with acute kidney injury: a pilot study. Perit Dial Int. 2011;31:422–9.CrossRefPubMedGoogle Scholar
  48. 48.
    Chionh CY, Soni SS, Finkelstein, et al. Use of peritoneal dialysis in AKI: a systematic review. Clin J Am Soc Nephrol. 2013;8:1649–60.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Bai ZG, Yang K, Tian J, et al. Bicarbonate versus lactate solutions for acute peritoneal dialysis. Cochrane Database Syst Rev. 2010;9:CD007034.Google Scholar
  50. 50.
    Stranger J, Rathgen K, Stahle H, et al. Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study. Clin Pharmacokinet. 2010;49:259–68.CrossRefGoogle Scholar
  51. 51.
    Khadzhynov D, Wagner F, Formella S, et al. Effective elimination of dabigatran by haemodialysis. A phase I single-centre study in patients with end-stage renal disease. Thromb Haemost. 2013;109:596–605.CrossRefPubMedGoogle Scholar
  52. 52.
    Warkentin TE, Margetts P, Connolly SJ, et al. Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. Blood. 2012;119:2172–4.CrossRefPubMedGoogle Scholar
  53. 53.
    Bouchard J, Ghannoum M, Bernier-Jean A, et al. Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran. Clin Toxicol. 2015;53:156–63.CrossRefGoogle Scholar
  54. 54.
    Neff LP, Cannon JW, Stewart IJ, et al. Extracorporeal organ support following trauma: the dawn of a new era in combat casualty critical care. J Trauma Acute Care Surg. 2012;75:S120–8.CrossRefGoogle Scholar
  55. 55.
    Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374:1351–63.CrossRefPubMedGoogle Scholar
  56. 56.
    Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ EMCO) Influenza Investigators. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA. 2009;302:1888–95.CrossRefGoogle Scholar
  57. 57.
    Wiegmann B, Maurer A, Zhang R, et al. Combined pulmonary and renal support in a single extracorporeal divice. ASAIO J. 2013;59:433–8.CrossRefPubMedGoogle Scholar
  58. 58.
    Cove ME, MacLaren G, Federspiel WJ, Kellum JA. Bench to bedside review: extracorporeal carbon dioxide removal, past present and future. Crit Care. 2012;16:232.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Cruz D, Bellomo R, Kellum JA, De Cal M, Ronco C. The future of extracorporeal support. Crit Care Med. 2008;36:S243–52.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

<SimplePara><Emphasis Type="Bold">Open Access</Emphasis> This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 2.5 International License (http://creativecommons.org/licenses/by-nc/2.5/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. </SimplePara> <SimplePara>The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.</SimplePara>

Authors and Affiliations

  1. 1.Burn CenterUS Army Institute of Surgical ResearchFort Sam HoustonUSA
  2. 2.Department of MedicineDavid Grant Medical CenterTravis AFBUSA

Personalised recommendations